Kristen BALTGALVIS

Follow

Person

Poway, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Method of using a bispecific antibody to conditionally inhibit a re...
- Patent number 11,111,305
- Issue date Sep 7, 2021
- TORCH THERAPEUTICS
- Todd M. Kinsella
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
ACVR2A-specific antibody and method of treatment of muscle atrophy
- Patent number 11,104,737
- Issue date Aug 31, 2021
- Rigel Pharmaceuticals, Inc.
- Todd M. Kinsella
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
In vivo engineered cereblon protein
- Patent number 10,781,239
- Issue date Sep 22, 2020
- VIVIDION THERAPEUTICS, INC.
- David Weinstein
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
IN VIVO ENGINEERED CEREBLON PROTEIN
- Publication number 20220298213
- Publication date Sep 22, 2022
- Vividion Therapeutics, Inc.
- David WEINSTEIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ACVR2A-SPECIFIC ANTIBODY AND METHOD OF USE THEREOF
- Publication number 20210380703
- Publication date Dec 9, 2021
- Rigel Pharmaceuticals, Inc.
- Todd M. KINSELLA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IN VIVO ENGINEERED CEREBLON PROTEIN
- Publication number 20210002337
- Publication date Jan 7, 2021
- Vividion Therapeutics, Inc.
- David WEINSTEIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ACVR2A-SPECIFIC ANTIBODY AND METHOD OF USE THEREOF
- Publication number 20190382496
- Publication date Dec 19, 2019
- Rigel Pharmaceuticals, Inc.
- Todd M. KINSELLA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CONDITIONALLY EFFECTIVE BISPECIFIC THERAPEUTICS
- Publication number 20190345252
- Publication date Nov 14, 2019
- TORCH THERAPEUTICS
- Todd M. KINSELLA
- C07 - ORGANIC CHEMISTRY